申请人:Borman Richard Anthony
                            
                            
                                公开号:US20090018150A1
                            
                            
                                公开(公告)日:2009-01-15
                            
                            Compounds of formulae: (I), (II), (IIIa), (IIIb), (IVa) and (IVb): or a pharmaceutically acceptable salt thereof, for use as pharmaceuticals, in particular for the treatment of a condition alleviated by antagonism of a 5-HT
2B
receptor.
                            化合物的分子式为:(I),(II),(IIIa),(IIIb),(IVa)和(IVb);或其药学上可接受的盐,用于制作药品,特别是用于治疗通过5-HT2B受体拮抗缓解的疾病。